OQROStart free trial
Politician trade (House)

Johnson & Johnson (JNJ): Rep. Julie Johnson (TX32) disclosed a sale $1K–$15K

Rep. Julie Johnson (TX32) disclosed a sale of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
28 days
Disclosure lag
Traded
Dec 18, 2025
Disclosed
Jan 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 10, 2025Congress · 1 personMembers of Congress: 2 sales
  2. Oct 16, 2025Federal contract · $384K obligatedDepartment of Defense awarded Johnson & Johnson: $384K obligated to date
  3. Oct 17, 2025InsiderOfficer sold ~$4.19M of JNJ shares in the open market
  4. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  5. Oct 31, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  6. Nov 5, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  7. Nov 13, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  8. Nov 20, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  9. Nov 26, 2025Insider · Their first buy on recordDirector purchased ~$258K of JNJ shares in the open market
  10. Dec 9, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  11. Dec 10, 2025Federal contract · $8K obligatedDepartment of Defense awarded Johnson & Johnson: $7.7K obligated to date
  12. Dec 18, 2025 · this disclosureCongressDisclosed sale of JNJ — reported range $1,001 - $15,000

What came next

  1. Jan 21, 2026Company filing · Form 8-K · ResultsReported its results
  2. Jan 23, 2026CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  3. Jan 26, 2026Insider · 1 personInsiders: 2 sales (~$22.1M)
  4. Feb 5, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 10.1%
  5. Feb 11, 2026Federal contract · $280K obligatedDepartment of Defense awarded Johnson & Johnson: $280K obligated to date
  6. Feb 13, 2026Insider · 1 personInsiders: 2 sales (~$10.1M)
  7. Feb 17, 2026Insider · 4 peopleInsiders: 9 sales (~$41.4M)
  8. Feb 18, 2026Insider · 1 personInsiders: 2 sales (~$5.5M)
  9. Feb 19, 2026Federal contract · $155K obligatedDepartment of Defense awarded Johnson & Johnson: $155K obligated to date
  10. Feb 20, 2026InsiderChair sold ~$325K of JNJ shares in the open market
  11. Feb 23, 2026Federal contract · $371K obligatedDepartment of Defense awarded Johnson & Johnson: $371K obligated to date
  12. Feb 27, 2026InsiderOfficer sold ~$1.01M of JNJ shares in the open market
  13. Mar 10, 2026FDAFDA device clearance: DePuy Synthes VOLT™ Medial Distal Femur 3.5 Plating System
  14. Mar 10, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  15. Mar 11, 2026FDAFDA device clearance: INHANCE™ Reverse Shoulder System
  16. Mar 17, 2026FDAFDA drug approval: Icotyde
  17. Mar 19, 2026Congress · 2 peopleMembers of Congress: 3 sales
  18. Mar 20, 2026Federal contract · $20K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $20K obligated to date
  19. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  20. Mar 26, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Julie Johnson (TX32)

The full history of Rep. Julie Johnson (TX32) is on the profile page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data